Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 12-Month High on Analyst Upgrade
Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report)’s stock price hit a new 52-week high on Friday after Scotiabank raised their price target on the stock from $10.00 to $12.00. Scotiabank currently has a sector outperform rating on the stock. Adaptive Biotechnologies traded as high as $8.56 and last traded at $8.52, with a volume […]
